Drug intelligence / Profile preview

grifola frondosa

Development stage
Phase 1
Modality
Small Molecules
Administration
Oral
01

Overview

Grifola frondosa is an edible medicinal mushroom native to East Asia, commonly known as maitake or hen-of-the-woods. It is used both as a food and a dietary supplement. Grifola frondosa contains a variety of bioactive compounds, primarily polysaccharides such as beta-glucans, glycoproteins, proteins, sterols, and phenolic compounds, which have demonstrated significant pharmacological potential. Mechanistically, its polysaccharide fractions are believed to exert effects by modulating the immune system, enhancing cellular responses through macrophage, NK cell, and T cell activation, and influencing cytokine production. Preclinical and limited clinical studies suggest it may have antitumor, antiviral, antibacterial, anti-inflammatory, antidiabetic, antihypertensive, and lipid-lowering effects. The mushroom and its extracts are marketed mainly as dietary supplements to support immune function and metabolic health, with ongoing research into roles in cancer adjunctive therapy, viral infection support, diabetes, hypertension, and PCOS. It is not a pharmaceutical drug and is not approved by regulatory agencies for treatment of any disease[1][2][3][5][6][7].

Other names
maitakehen-of-the-woodshui-shu-hua
02

Targets

CLEC7A (Dectin-1)HBV Pol (Hepatitis B virus polymerase)

Beyond the preview

Go deeper on grifola frondosa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on grifola frondosa.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call